Status:
COMPLETED
Evaluation of Efficacy and Patient Acceptance of Sound Amplifier Téo First, in Mild and Moderate Presbycusis Patient 60 Years of Age and Older, With no Previous Hearing Aid
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Mild and Moderate Presbycusis
Eligibility:
All Genders
60-100 years
Phase:
NA
Brief Summary
A personal sound amplifying device (PASP) like Teo First is a wearable electronic product that is not intended to compensate for impaired hearing, but rather is intended for non-hearing impaired consu...
Eligibility Criteria
Inclusion
- Wish to increase hearing
- Moral commitment to use the device
- Ability to understand the study
- Mild and moderate presbycusis (20 to 50 dB average hearing loss at 500, 1000, 2000 Hz and 4000 Hz)
- Patient 60 years of age and older,
- No previous hearing aid
Exclusion
- Inability to use the device
- Previous use of a hearing aid
- local intolerance
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT01815788
Start Date
April 1 2013
End Date
June 1 2014
Last Update
November 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nice
Nice, France, 06000